PERSPECTA

News from every angle

← Back to headlines

ImmunityBio Investors Face May 26, 2026, Deadline in Securities Fraud Lawsuit

Investors in ImmunityBio, Inc. (IBRX) have been alerted to a May 26, 2026, deadline to participate in a securities fraud class action lawsuit against the company.

24 Apr, 16:40 — 24 Apr, 16:40
PostShare

Sources

Showing 1 of 1 sources
globe-and-mailHigh115d ago

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Deadline in Securities Fraud Class Action Lawsuit - The Globe and Mail

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Deadline in Securities Fraud Class Action Lawsuit  The Globe and Mail

Read full article →

Related Stories

Mark Cuban Criticizes Ro Khanna's Wealth Tax Proposal

2h ago

Wall Street Closes Lower Despite Strong Earnings Season

4h ago

Cornerstone Funds Declare Monthly Dividends and Announce 2026/2027 Distributions

8h ago

The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results

9h ago